
Sign up to save your podcasts
Or


Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK
By BBC Radio 44.7
3232 ratings
Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK

7,913 Listeners

376 Listeners

863 Listeners

1,067 Listeners

50 Listeners

40 Listeners

5,576 Listeners

1,808 Listeners

1,729 Listeners

1,018 Listeners

2,113 Listeners

1,952 Listeners

790 Listeners

73 Listeners

227 Listeners

75 Listeners

108 Listeners

745 Listeners

143 Listeners

3,245 Listeners

1,600 Listeners

3,858 Listeners

851 Listeners

195 Listeners

48 Listeners